This content is from: Patents

In-house roundup: Pay for delay opposed by all; AI spurs pharma IP refocus; energy digitalisation pushes patent overhaul

Managing IP rounds up the latest news and analysis from patent-focused businesses


Money

Seminal pay for delay law opposed by pharma companies 

Generics and innovator companies say they don’t like the new and ‘badly-worded’ legislation introduced by California that bans drug settlements and could actually raise drug prices. Read more... 

AI alliances will push pharma refocus on patent bundles and licensing 

Pharma companies say AI’s potential to make R&D models more efficient and less expensive will drive the development of therapeutics that require different IP strategies. Read more... 

Energy digitalisation spurs industry IP overhaul 

SBM Offshore and IFP Energies explain how the energy sector has embraced digital technologies such as AI to drive efficiencies – and how that move is creating data rights and eligibility challenges. Read more... 


The material on this site is for law firms, companies and other IP specialists. It is for information only. Please read our Terms and Conditions and Privacy Notice before using the site. All material subject to strictly enforced copyright laws.

© 2020 Euromoney Institutional Investor PLC. For help please see our FAQs.

Related

Instant access to all of our content. Membership Options | One Week Trial